Evidence 2017

Topics

• Application of RWE in clinical development
• How to embrace digital technologies in outcomes research
• Can we achieve better clinical development for rare diseases?
• Partnerships in RWE
• How to interpret and use RWD
• How to integrate payer expectations in early drug development
• Comparing different approaches to data analysis and HTA in mature versus emerging markets
• Maximise future opportunities in RWE
• Sustaining value and quality in healthcare

Who should Attend

• Market Access
• HTA
• Outcomes Research
• Health Economics
• Epidemiology
• Health Policy
• Pharmacoeconomics
• Pricing & Reimbursement
• Clinical research
• Clinical trials
• Medical Affairs
• Post marketing Surveillance
• Pharmacoepidemiology